liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Attenuation of eph receptor kinase activation in cancer cells by coexpressed ephrin ligands
Sanford-Burnham Medical Research Institute, San Diego, California, USA / Department Pharmacology, University of Bologna, Bologna, Italy.
Sanford-Burnham Medical Research Institute, San Diego, California, USA.
Sanford-Burnham Medical Research Institute, San Diego, California, USA.
Sanford-Burnham Medical Research Institute, San Diego, California, USA.
Show others and affiliations
2013 (English)In: PLoS ONE, ISSN 1932-6203, E-ISSN 1932-6203, Vol. 8, no 11, e81445- p.Article in journal (Refereed) Published
Abstract [en]

The Eph receptor tyrosine kinases mediate juxtacrine signals by interacting "in trans" with ligands anchored to the surface of neighboring cells via a GPI-anchor (ephrin-As) or a transmembrane segment (ephrin-Bs), which leads to receptor clustering and increased kinase activity. Additionally, soluble forms of the ephrin-A ligands released from the cell surface by matrix metalloproteases can also activate EphA receptor signaling. Besides these trans interactions, recent studies have revealed that Eph receptors and ephrins coexpressed in neurons can also engage in lateral "cis" associations that attenuate receptor activation by ephrins in trans with critical functional consequences. Despite the importance of the Eph/ephrin system in tumorigenesis, Eph receptor-ephrin cis interactions have not been previously investigated in cancer cells. Here we show that in cancer cells, coexpressed ephrin-A3 can inhibit the ability of EphA2 and EphA3 to bind ephrins in trans and become activated, while ephrin-B2 can inhibit not only EphB4 but also EphA3. The cis inhibition of EphA3 by ephrin-B2 implies that in some cases ephrins that cannot activate a particular Eph receptor in trans can nevertheless inhibit its signaling ability through cis association. We also found that an EphA3 mutation identified in lung cancer enhances cis interaction with ephrin-A3. These results suggest a novel mechanism that may contribute to cancer pathogenesis by attenuating the tumor suppressing effects of Eph receptor signaling pathways activated by ephrins in trans.

Place, publisher, year, edition, pages
San Francisco, CA, United States: Public Library of Science , 2013. Vol. 8, no 11, e81445- p.
National Category
Cell and Molecular Biology
URN: urn:nbn:se:liu:diva-107050DOI: 10.1371/journal.pone.0081445ISI: 000327670300032PubMedID: 24348920ScopusID: 2-s2.0-84896715497OAI: diva2:721400
Available from: 2014-06-04 Created: 2014-06-04 Last updated: 2015-11-18Bibliographically approved

Open Access in DiVA

fulltext(1133 kB)64 downloads
File information
File name FULLTEXT01.pdfFile size 1133 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Perez-Tenorio, Gizeh
In the same journal
Cell and Molecular Biology

Search outside of DiVA

GoogleGoogle Scholar
Total: 64 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 44 hits
ReferencesLink to record
Permanent link

Direct link